Who we are

Corticalis AS was founded in 2006 by leading researchers and clinicians with extensive experience developing and marketing dental implants and regenerative therapies. The company aims to develop its own innovative and sustainable medical devices for professional follow-up of patients treated for oral diseases and wounds on the skin and mucous membranes.

Corticalis places particular emphasis on creating and promoting alternatives to antibiotic-based antimicrobial agents. The increased use of antibiotics is causing bacteria and other microbes to become resistant to medication. Corticalis offers effective alternatives to antibiotics so that this problem can be avoided.

Today, the company has finished products for maintaining teeth and dental implants that are prone to gum disease. These products, developed with a focus on patient comfort and effectiveness, offer a comprehensive solution for oral health. Corticalis has also developed a nature-mimicking, non-animal product for surgically rebuilding supportive tissue around teeth and implants where it has been lost due to disease. These products will be marketed through a global network of established distributors.

During its development phase, Corticalis has undergone evaluations and received significant support from the Research Council of Norway and the European Union. The company has three times been awarded the European Commission’s “Seal of Excellence,” an essential confirmation of its projects and products' high quality and societal value.

Contact us today!

Our Mission

We aim to develop evidence-based, nature-inspired, and antibiotic-free solutions to provide safe, effective, and sustainable PeriHealth® maintenance, implant support and wound care.

-

Antibiotic-Free Implant Care

Eliminating antibiotics in implant care, addressing the growing issue of microbial resistance, and minimizing the risk of complicated infections. 

-

Safety and Sustainability

Improving the impact of implant treatments with efficient, clean and sustainable devices produced with free from animal-derived ingredients.

-

PeriHealth for All

Offering cost-effective, high-quality treatments worldwide, ensuring accessible solutions for all patients in the post-antibiotic era.

Staff

Ikon - person

Ståle Petter Lyngstadaas

Prof., DDS, PhD, BEng

Founder and dentist with background in molecular biology and biomaterials. As Managing Director, Lyngstadaas oversees Corticalis’ strategic direction and daily operations. He ensures cross-functional collaboration to drive the company’s vision and maintain sustainable growth. R&D Experience from the biotech industry.

Ikon - person

Jan Eirik Ellingsen

Prof., DDS, PhD

Founder, dentist and specialist in prosthodontics and implantology. Ellingsen leads the board and oversees clinical research, drawing on his extensive experience to guide Corticalis’ commitment to evidence-based, patient-focused innovation. Experience in implant product commercialisation.

Ikon - person

Håvard Jostein Haugen

Prof., PhD, MEng

Haugen spearheads research, development, and manufacturing at Corticalis. He has long-term experience in biomaterials, innovation, and translation. His focus on innovation and quality control ensures that products meet the highest industry standards.

Ikon - person

Angela De Lauretis

MEng

Chemical engineer and industrial PhD candidate committed to driving innovation in the MedTech industry. She manages day-to-day laboratory operations, plays a key role in production processes, and upholds consistent quality across all Corticalis products.

Ikon - person

Chiara Ravaioli

MSc

Passionate about advancing sustainable healthcare solutions with expertise in economics, quantitative methods and health policy. She provides expert product support at Corticalis, delivering business solutions tailored to the needs of clinicians and patients.

Clinical Advisory Board

Ikon - person

Mariano Sanz

DDS, PhD

Professor and Head of Periodontology at the Complutense University of Madrid. With a background in medicine and dentistry and a specialisation in periodontology from UCLA, he is internationally recognised for his leadership in oral health innovation.

Ikon - person

Morten Klepp

DDS, MSc

A highly qualified periodontist at Colosseum Tannlege Solakrossen, specialising in advanced periodontal treatment and implantology. Educated at the University of Minnesota and the University of Oslo, he offers expert care for periodontal diseases, implant placement, and long-term oral health maintenance.

Ikon - person

Lisa Heitz-Mayfield

DDS, PhD

Adjunct Professor at the University of Western Australia and the University of Sydney. Dr Heitz-Mayfield also runs a specialist periodontal practice in Perth, combining extensive academic expertise with clinical care. She additionally serves as Editor-in-Chief of Clinical Oral Implants Research.

Ikon - person

Leonardo Trombelli

DDS, PhD

Professor and Head of Periodontology at the University of Ferrara. With extensive expertise in periodontal regeneration, soft-tissue treatment, and peri-implant health, he has been instrumental in advancing clinical and translational research in these areas.

Board

Ikon - person

Jan Eirik Ellingsen

Chairman

Founder, dentist and specialist in prosthodontics and implantology. Ellingsen leads the board and oversees clinical research, drawing on his extensive experience to guide Corticalis’ commitment to evidence-based, patient-focused innovation. Experience in implant product commercialisation.

Ikon - person

Ståle Petter Lyngstadaas

Board member

Founder and dentist with background in molecular biology and biomaterials. As Managing Director, Lyngstadaas oversees Corticalis’ strategic direction and daily operations. He ensures cross-functional collaboration to drive the company’s vision and maintain sustainable growth. R&D Experience from the biotech industry.

Ikon - person

Bjørn Gabriel Reed

Board member

Corporate lawyer and previous managing partner at the law firm BAHR. Reed is now independent advisor and arbitrator. He brings wide experience from board positions in industrial, financial and commercial listed and non-listed businesses.  

Ikon - person

Mikael Sander

Board member

Broad global experience from various senior leadership and board positions in pharma and MedTech industry, lastly with Dentsply Sirona Implants and Bactiguard AB, focusing on dental implants and infection prevention. 

Ikon - person

Erlend Basmo Ellingsen

Board member

Managing partner and CEO at HitecVision, with broad experience in merger and acquisition and board positions. He brings financial and business expertise to the company.

Ikon - person

René Willi

Board member

CEO of Medmix AG, formerly President of the Global Oral Surgery Group at Henry Schein Inc. and Head of the Surgical Business Unit at Straumann Group. He has served on the boards of Medmix AG, Camlog Biotechnology, BioHorizons Inc., and Biotech Dental SA.

Our collaboration Partners